MGMT and central nervous system cancer: MGMT promoter methylation is an independent favorable prognostic factor of gliomas.[9] A meta-analysis analyzing 15 articles has shown that the MGMT methylation rate in normal lung tissue, NSCLC tissue, plasma, and the bronchial lavage fluid were 16%, 38%, 23%, and 39%, respectively.